Jubilant HollisterStier General Partnership

FDA inspection history in Kirkland, Canada, 2014 to 2026

5
Form 483s
1
Warning letter
1
Close-out

Every document, by year

  • Warning letter
  • Form 483
  • Close-out

2014: one close-out letter and one Form 483; 2015: one Form 483; 2018: one Form 483; 2023: one Form 483; 2024: one Form 483; 2026: one warning letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2014–15Two Form 483s and one close-out letter, at Kirkland, Canada.
  2. 2018One Form 483, at Kirkland, Canada.
  3. 2023–26Two Form 483s and one warning letter, at Kirkland, Canada.
  4. 2024The longest 483 on file: 15 observations over 19 pages at Kirkland, Canada.

Cited most

Across all Jubilant HollisterStier General Partnership observations on file

The complete Jubilant HollisterStier General Partnership file.

All 7 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$589$693

15% off buying them one by one

Sites

Also: two documents not tied to a site.

Documents

7 on file, newest first
DateDocumentPrice
2026-05-28Warning letter Warning letter$99
2024-06-14483 Form 483$99
2023-02-28483 Form 483$99
2018-06-01483 Form 483$99
2015-12-10483 Form 483$99
2014-09-05Close-out Close-out letter$99
2014-03-06483 Form 483$99

FEI number 3001623073 · most recent document May 28, 2026

About Jubilant HollisterStier General Partnership

How many FDA Form 483s has Jubilant HollisterStier General Partnership received?

FDA Intel has 5 Form 483s on file for Jubilant HollisterStier General Partnership; the most recent is dated Jun 14, 2024.

When was Jubilant HollisterStier General Partnership last inspected by FDA?

The most recent FDA inspection document on file for Jubilant HollisterStier General Partnership is a Form 483 dated Jun 14, 2024, for the site in Kirkland, Canada.

What did FDA cite at Jubilant HollisterStier General Partnership?

The regulations cited most in the observations on file for Jubilant HollisterStier General Partnership are 21 CFR 211.42 (Design and construction features), 5 times; 21 CFR 211.113 (Control of microbiological contamination), 4 times; 21 CFR 211.160 (General requirements), 4 times.

Has Jubilant HollisterStier General Partnership received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Jubilant HollisterStier General Partnership; the most recent is dated May 28, 2026.